Corticosteroids in Alcoholic Hepatitis

Status Recruiting

Clinical Trial Summary

Approximately 50% of patients admitted for severe AH will have spontaneous improvement of liver function before initiation of therapy (ie decrease in mDF between hospital admission and initiation of steroids). These patients have a better prognosis than patients without spontaneous improvement of liver function. It has never been demonstrated that corticosteroids improve survival in severe AH patients with spontaneous improvement of liver function. Our hypothesis is that severe AH patients with spontaneous improvement of liver function represent a group who could most benefit from steroids

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03160651
Study type	Interventional
Source	Erasme University Hospital
Contact	Christophe Moreno, MD, PhD
Phone	+32 2 5553714
Email	christophe.moreno@erasme.ulb.ac.be
Status	Recruiting
Phase	N/A
Start date	February 9, 2018
Completion date	December 2022

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04066179` - Efficacy of Monotherapy vs Combination Therapy of Corticosteroids With GCSF in Severe Alcoholic Hepatitis Patients.	N/A
Completed	`NCT03732586` - Effect of Omega 5 Fatty Acid as an Adyuvant Treatment to Prednisone in Patients With Severe Alcoholic Hepatitis	N/A
Completed	`NCT01476995` - Prognostic Indicators as Provided by the EPIC ClearView	N/A
Completed	`NCT00962442` - N-Acetylcysteine in Severe Acute Alcoholic Hepatitis	Phase 3
Not yet recruiting	`NCT06307522` - MRG-001 in Patients With Alcoholic Hepatitis	Phase 2
Recruiting	`NCT05018481` - HA35 Moderate Alcoholic Hepatitis (AH) Study	Early Phase 1
Completed	`NCT04544020` - Changes in gUt micRobiota After Enteral Feeding (in Alcoholic Hepatitis)
Recruiting	`NCT04088370` - Peripheral Blood Mononuclear Cells Response In Healthy Controls, Heavy Drinkers, and Patients With Alcoholic Hepatitis
Completed	`NCT04235855` - EUS Guided Liver Biopsy - Will it Give Better Yield, More Tissue With Less Complication?	N/A
Active, not recruiting	`NCT02344680` - Liver Fibrosis in Zambian HIV-HBV Co-infected Patients
Completed	`NCT00851981` - Randomized, Controlled Trial of S-adenosylmethionine in Alcoholic Liver Disease	Phase 2
Completed	`NCT04084522` - Effect of Saturated Fat (Desi Ghee) on Gut-Liver Axis in Alcoholic Hepatitis	N/A
Completed	`NCT05840640` - Granulocyte Colony Stimulating Factor Four Week Plus N-Acetyl Cysteine in Severe Alcoholic Hepatitis	Phase 4
Recruiting	`NCT03069300` - N-ACetylcysteine to Reduce Infection and Mortality for Alcoholic Hepatitis	Phase 3
Terminated	`NCT02039219` - Trial of Obeticholic Acid in Patients With Moderately Severe Alcoholic Hepatitis (AH)	Phase 2
Completed	`NCT01245257` - Effects of Prednisolone and Pentoxifylline on the Regulation of Urea Synthesis in Alcoholic Hepatitis	N/A
Completed	`NCT02019056` - Efficacy and Safety of MG in the Patients With Alcoholic Fatty Liver Disease and Alcoholic Hepatitis	Phase 2
Completed	`NCT00388323` - Adipose Tissue Involvement in Alcohol-induced Liver Inflammation in Human	N/A
Recruiting	`NCT03845205` - Alcohol Treatment Outcomes Following Early vs. Standard Liver Transplant for SAH	N/A
Recruiting	`NCT03703674` - GCSF in Alcoholic Hepatitis	Phase 4